ÂÜÀòÂÒÂ×

Ujjal Sarkar, Ph.D., is an accomplished scientist specializing in drug metabolism and pharmacokinetics (DMPK) with extensive experience in the pharmaceutical industry and academic research. Currently serving as a Curious Drug Hunter and Translational Biotransformation Science Lead at Cerevel Therapeutics, Ujjal Sarkar focuses on innovative therapeutic interventions for neurodegenerative diseases. Prior to this role, Ujjal Sarkar contributed to AstraZeneca as an ADME Mechanistic Drug-Biotransformation Specialist, where Ujjal Sarkar advanced drug discovery processes in oncology. Ujjal Sarkar's career includes valuable positions at the Defense Advanced Research Projects Agency (DARPA), the Massachusetts Institute of Technology (MIT), and the University of Missouri, where Ujjal Sarkar conducted significant research in drug metabolism, biomarker discovery, and small molecule studies. Ujjal Sarkar holds advanced degrees from prestigious institutions, including degrees in Medicinal Chemistry and Bioorganic Chemistry.